I-Mab, WuXi enter into long-term strategic manufacturing partnership

I, April 24 -- Mab Biopharma (I-Mab), a biotech company focusing exclusively on innovative biologics in immuno-oncology and auto-immune diseases, and WuXi Biologics, a leading global open-access biolo... Read More

SpeeDx receives funding from U.S. Venture Firm

Singapore, April 24 -- Australia based SpeeDx Pty. Ltd. has announced further series A funding received by new investor partners, Northpond Ventures, LP - a U.S.-based, formative stage venture capital... Read More

NUS researchers find new biomarkers associated with chemobrain

Singapore, April 24 -- Cognitive impairment associated with cancer, also known as "chemobrain", has gained recognition as a complication of the disease and its treatment, as it can negatively affect t... Read More

LifeArc licenses lead stage molecules to Daiichi Sankyo

Singapore, April 24 -- LifeArc, one of the UK's leading medical research charities, has signed a deal to license an ion channel drug discovery programme to Daiichi Sankyo Company, Limited. Small mole... Read More

mfine raises $17.2 M to create largest virtual healthcare delivery network

Mfine, a health, April 24 -- tech AI startup from India, has raised $17.2 million in Series B funding. The investment was led by SBI Investment, a Japan-based venture capital firm and a subsidiary of ... Read More

Macrogen, Exosome Plus to jointly develop exosome-based diagnostic & treatment solutions

Singapore, April 24 -- The precision medicine and biotechnology company Macrogen has announced on April 24 that it had signed a supply contract with Exosome Plus on April 19 to become the exclusive bu... Read More

Velabs collaborates with Chiome for GPCR-Specific functional antibody screening

Singapore, April 24 -- Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, announced that it has entered into an agreement with Chiome Bioscience, Inc., Toky... Read More

A*Star, NEA & NCID develop diagnostic test for mosquito-borne diseases

Singapore, April 24 -- Scientists from Singapore's Agency for Science, Technology and Research (A*STAR), in collaboration with the Environmental Health Institute (EHI) of the National Environment Agen... Read More

A*STAR & Duke-NUS unveils the map to design treatment for dengue and zika viruses

Singapore, April 24 -- Scientists from the Agency for Science, Technology and Research's (A*STAR) Genome Institute of Singapore (GIS), together with scientists from Duke-NUS Medical School and A*STAR'... Read More

Malaria vaccine pilot launched in Malawi

Singapore, April 24 -- WHO welcomes the Government of Malawi's launch of the world's first malaria vaccine in a landmark pilot programme. The country is the first of three in Africa in which the vacci... Read More